Tocilizumab in patients with severe COVID-19: a retrospective cohort study

BACKGROUND: No therapy is approved for COVID-19 pneumonia. The aim of this study was to assess the role of tocilizumab in reducing the risk of invasive mechanical ventilation and death in patients with severe COVID-19 pneumonia who received standard of care treatment. METHODS: This retrospective, ob...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Lancet Rheumatol
Main Authors: Guaraldi, Giovanni, Meschiari, Marianna, Cozzi-Lepri, Alessandro, Milic, Jovana, Tonelli, Roberto, Menozzi, Marianna, Franceschini, Erica, Cuomo, Gianluca, Orlando, Gabriella, Borghi, Vanni, Santoro, Antonella, Di Gaetano, Margherita, Puzzolante, Cinzia, Carli, Federica, Bedini, Andrea, Corradi, Luca, Fantini, Riccardo, Castaniere, Ivana, Tabbì, Luca, Girardis, Massimo, Tedeschi, Sara, Giannella, Maddalena, Bartoletti, Michele, Pascale, Renato, Dolci, Giovanni, Brugioni, Lucio, Pietrangelo, Antonello, Cossarizza, Andrea, Pea, Federico, Clini, Enrico, Salvarani, Carlo, Massari, Marco, Viale, Pier Luigi, Mussini, Cristina
פורמט: Artigo
שפה:Inglês
יצא לאור: Elsevier Ltd. 2020
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7314456/
https://ncbi.nlm.nih.gov/pubmed/32835257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2665-9913(20)30173-9
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים